JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: On the other hand, regarding the potential role of JAK2 in the pathophysiology of CML and treatment efficacy, it may be valuable to assess the levels of JAK2 gene expression or JAK2 protein.